Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest announcement is out from Atara Biotherapeutics ( (ATRA) ).
Atara Biotherapeutics has appointed Eric Hyllengren as Chief Operating Officer, in addition to his role as Chief Financial Officer, highlighting his extensive experience at Amgen and within Atara since 2018. With a background in finance from Notre Dame and an MBA from Kellogg, Hyllengren’s promotion comes without any linked arrangements, family ties, or related transactions, now earning a $520,000 annual salary.
For a thorough assessment of ATRA stock, go to TipRanks’ Stock Analysis page.
